Instruction for use: Eksalb

ATX Code D07XA Low-active corticosteroids in combination with other drugs

Pharmacological group

Glucocorticosteroids

Other immunomodulators

Nosological classification (ICD-10)

B00.0 Herpetic eczema

Herpes skin, Herpes on the skin, Eczema herpetiform Kaposi, Acute herpetic skin disease, Primary herpetic infection of the skin and mucous membranes, Herpes simplex skin and mucous membranes, Herpes simplex with skin and mucous membrane damage, Herpetic infection of the skin, Herpetic lesions of the skin, Herpetic dermatitis, Herpetic lesions of the skin, Herpetic lesions of the skin and mucous membranes, Recurrent herpetic infection of the skin, Simple skin herpes, Herpes-viral infections, Herpetic infection, Herpetic infections, Herpetic lesions, Latent herpetic infection, Neonatal herpes, Recurrent herpes infection, Chronic recurrent herpesvirus infection, Chronic recurrent herpetic infection

B00.1 Herpetic vesicular dermatitis

Herpetic vesicular dermatitis of lips, Bubbling herpetic dermatitis, Herpes

B02 Shingles [herpes zoster]

Herpes zoster, Shingles Herpes, Localized shingles, Infection caused by the herpes zoster virus, Shingles

L00-L08 Infections of the skin and subcutaneous tissue

L20 Atopic dermatitis

Itchy atopic eczema, Common neurodermatitis, Allergic skin diseases, Allergic skin diseases of non-infectious etiology, Allergic skin diseases of non-microbial etiology, Allergic skin diseases, Allergic skin lesions, Allergic manifestations on the skin, Allergic dermatitis, Allergic diathesis, Allergic itching dermatosis, Allergic Skin Disease, Allergic skin irritation, Dermatitis allergic, Atopic dermatitis, Dermatosis allergic, Diathesis exudative, Skin Allergic Disease, Skin allergic reaction to medicinal and chemical preparations, Skin reaction to medication, Skin and allergic disease, Acute eczema, Chronic atopic dermatitis, Exudative diathesis, Itching allergic dermatosis

L21 Seborrheic dermatitis

Dermatitis seborrheic, Increased sebum separation, Seborrheic Eczema, Seborrheic dermatitis of the scalp, Seborrheic pyodermatitis, Seborrhea, Eczema seborrheic

L27 Dermatitis due to substances taken internally

L29 Itching

Itching with partial obstruction of the biliary tract, Dermatitis itchy, Dermatosis with persistent itching, Other itching dermatoses, Itching dermatoses, Itching allergic dermatosis, Itching dermatitis, Itching itch, Excruciating itching, Severe itching, Endogenous itching, Skin itching with dermatosis, Limited itching dermatitis, Itching of the skin, Itchy scalp, Itching eczema

L30.3 Infectious dermatitis

Microbial skin infections, Dermatitis with concomitant bacterial infections, Dermatitis in the presence of a bacterial infection or suspected of it, Infected eczema of external auditory canal, Secondarily infected dermatosis, Erythema migrans, Secondarily infected dermatoses , Dermatitis re-infected, Infectious dermatitis, Dermatitis infected, Dermatoses complicated by a secondary infection, Dermatoses complicated by primary and secondary infection, Dermatoses complicated by primary and / or secondary infection, Infected eczema, Infected dermatitis, Infected dermatosis, Migrating erythema, Microbial eczema, Chronic migratory erythema, Eczema is infected, Erythema Migrating, Bacterial dermatitis, Erythema migratory chronic, Superinfectant dermatitis, Necrolytic Migrating erythema

L30.9 Dermatitis, unspecified

Allergic dermatoses complicated by a secondary bacterial infection, Anal eczema, Bacterial maturation, Varicose Eczema, Venous dermatitis, Inflammation of the skin, Inflammation of the skin upon contact with plants, Inflammatory Skin Diseases, Inflammatory skin reactions, Inflammatory processes of the skin, Hypostatic dermatitis, Fungal Eczema, Fungal dermatosis, Dermatitis, Dermatitis is stagnant, Dermatitis and eczema in the anal area, Dermatitis acute contact, Perianal dermatitis, Dermatosis, Dermatosis of the scalp, Dermatosis of psoriasis, Dermatosis with persistent itching, Dermatoses, Dermatoses itchy, Other itching dermatoses, Significant eczematous manifestations, Itching with, dermatoses, Itching eczema, True eczema, Skin reaction to insect bites,Skin itching with dermatosis, Constitutional eczema, Weeping eczema, Drowsing inflammatory skin disease, Dying Infectious-Inflammatory Skin Disease, Non-allergic dermatitis, Nummular eczema, Acute contact eczema, Acute inflammatory skin disease, Acute dermatosis, Acute severe dermatosis, Perianal dermatitis, Superficial dermatosis, Subacute Contact Eczema, Simple dermatitis, Occupational dermatitis, Psychogenic dermatosis, Bubble dermatitis of newborns, Pustular eruptions, Irritation and redness of the skin, Low-flammable eczema, Dry atrophic eczema, Dry eczema, Toxic dermatitis, Ear eczema like dermatitis, Chronic eczema, Chronic dermatosis, Chronic common dermatosis, Scaly papular dermatosis, Eczema, Eczema anal region, Eczema of the hands, Eczema Contact, Eczema lichenized, Eczema Nummular, Eczema acute, Eczema acute contact, Eczema subacute, Eczematous dermatitis, Eczema-like rashes, Ecome exogenous, Endogenous eczema, Gluteal dermatitis, Restricted itchy dermatitis

L40.0 Psoriasis vulgaris

Psoriatic plaque, Vulgar psoriasis, Psoriasis vulgaris, Chronic vulgar plaque psoriasis

L40.1 Generalized pustular psoriasis

Pustular psoriasis

L40.3 Palmar and plantar pustulosis

Pustular psoriasis

M60.0 Infectious myositis

Abscess of muscle, Infections of soft tissues, Myositis is infectious, Specific infectious processes in soft tissues, Piomyositis

M65.1 Other infectious tendosynovitis

Infections of soft tissues, Tendosinovit infectious

M71.1 Other infectious bursitis

Bursitis infectious, Infections of soft tissues, Bacterial bursitis

T30 Thermal and chemical burns, unspecified

Pain syndrome with burns, Pain in burns, Pain with burns, Sluggishly healing post-burn wounds, Deep burns with a wet scab, Deep burns with abundant compartments, Deep burn, Laser burn, Burn, Burn of rectum and perineum, Burn with mild exudation, Burn disease, Burn injury, Superficial burn, Superficial burn of I and II degree, Superficial skin burns, After-burn trophic ulcer and wound, Post-burn complication, Loss of fluid in burns, Sepsis burn, Thermal burns, Thermal skin lesions, Thermal burn, Trophic after-burn ulcers, Chemical burn, Surgical burn

T78.4 Allergy, unspecified

Allergic reactions to insulin, Allergic reactions to insect stings, Allergic reactions similar to systemic lupus erythematosus, Allergic diseases, Allergic diseases of mucous membranes, Allergic diseases and conditions resulting from increased release of histamine, Allergic diseases of mucous membranes, Allergic symptoms, Allergic symptoms in the mucous membranes, Allergic reactions, Allergic reactions caused by insect bites, Allergic reactions, Allergic conditions, Allergic laryngeal edema, allergopathy, allergic conditions, Allergy, House dust allergy, Anaphylaxis, Cutaneous reactions to medications, Skin reaction to insect stings, Cosmetic allergy, Drug allergy, Acute allergic reaction, Laryngeal edema allergic genesis and background radiation, Food and drug allergy

W57 Bite or sting with non-toxic insect and other non-venous arthropods

Allergic reaction to insect bites, Skin reaction after insect bite, Reactions to insect bites, Mosquito bite, Bite of bloodsucking insects, A bite of an insect, The bite of the wasp

Composition and form of release

1 g of ointment contains 2.5 mg of hydrocortisone in a water-oil emulsion and 166.7 mg of an aqueous suspension of inactivated bacteria culture consisting of cell particles and exchange products of 150 million Staphylococcus aureus bacteria, 15 million fecal enterococci bacteria, 15 million Pseudomonas aeruginosa and 150 million bacteria of E. coli; In tubes of 25 grams, in a box of 1 tube.

pharmachologic effect

Pharmacological action - anti-inflammatory, immunomodulating, antipruritic.

It forms a specific and stimulates nonspecific immunity.

Pharmacodynamics

Strengthens the proliferation of T-lymphocytes, the production of immunoglobulins A, G and increases the immune response; Stimulates natural defense mechanisms and reduces the susceptibility of affected tissues to infection. Inhibits stimulated histamine release by mast cells and basophilic granulocytes, liberation of lysosomal enzymes, migration of inflammatory cells, synthesis of PG (prostaglandins) and other mediators of inflammation, reduces vascular permeability, inflammatory edema, connective tissue reactivity in the inflammation zone, accelerates wound healing. Antiallergic and immunosuppressive effects are manifested in a decrease in the synthesis of leukotrienes, inhibition of T-lymphocyte function, chemotaxis of monocytes,

Clinical Pharmacology

Considering the fatty basis of the ointment, it is recommended to use it primarily for normal or decreased function of the sebaceous glands.

Indications

Eczema - acute and subacute, dyshidrotic (accompanied by itching), seborrheic, microbial, external auditory meatus, nasal passages, in infants, palms caused by cracks, calluses; Eczematic-like rashes (infected or caused by medication); Acute wetting infections and inflammatory skin diseases (dermatitis); Insect bites; Psoriasis (vulgar, with eczematism, eczematous), skin burns. Prevention of secondary suppuration with herpetiform diseases (herpes lips, shingles).

Contraindications

Hypersensitivity, chicken pox, fungal diseases, inflammatory diseases of the facial skin, erysipelas (wound etiology), specific skin lesions (including (including (including) tuberculosis, syphilis, gonorrhea) in the field of application.

Side effects

Atrophy of skin areas, telangiectasia, striae, steroid acne, inflammatory diseases of the facial skin (including dermatitis around the mouth), increasing hair growth on the skin (with prolonged use in a high dose); Allergic reactions; Glucocorticoid systemic effects (with long-term use, in high doses, on a vast surface).

Interaction

Strengthens the action, incl. Side effects, corticosteroids.

Dosing and Administration

Outwardly. Apply a thin layer on the affected areas 2 times a day; If necessary, supplemented with bandages. After each skin cleansing, repeated application of the ointment is necessary. In case of acute wetting skin diseases, incl. Infected - after the previous application it is recommended to apply gauze dressings moistened with distilled (boiled) water 2 times a day. In psoriasis, it is possible to use protective ("deaf") dressings.

storage Conditions

At a temperature not exceeding 25 ° C.

Keep out of the reach of children.

Shelf life

3 years.

Do not use after the expiry date printed on the package.